Clinical Classification of Lung Cancer into Two Types In the medical field, lung cancer is clinically classified into two major categories: small cell lung cancer and non-small cell lung cancer. Don’t underestimate these two distinctions, which are especially important because these two types of lung cancer are distinctly different in terms of treatment options. Small cell lung cancer accounts for about 20% of lung cancers, with short multiplication time and rapid progression of tumor cells, and is often associated with endocrine abnormalities or carcinoid syndrome. Since these lung cancer patients have early metastases and are sensitive to chemotherapy, the mainstream treatment for small cell lung cancer is systemic chemotherapy and surgery is contraindicated. It should be noted that although small cell lung cancer is sensitive to chemotherapy, it is prone to recurrence and spread, and prophylactic cranial radiotherapy should be administered with extreme caution. Non-small cell lung cancer includes pathological squamous carcinoma, adenocarcinoma, and alveolar cell carcinoma, accounting for approximately 80% of cases. Among them, squamous carcinoma is the most common, accounting for about 50%. It has a slow growth rate, a long course, and is relatively sensitive to both radiotherapy and chemotherapy. Adenocarcinoma is relatively common in women and generally grows more slowly, but sometimes bloodstream metastases occur early. Alveolar cell carcinoma has the lowest incidence rate among all types of lung cancer, is more common in women, is more differentiated, and grows slowly. What are the horrible toxic side effects of radiotherapy and chemotherapy for lung cancer? Chemotherapy is very common in the treatment of lung cancer. Doctors will repeatedly administer the drugs as long as the patient can tolerate the toxic side effects of chemotherapy to maximize the elimination of cancer cells in order to partially or completely control the tumor. However, due to the poor selectivity of chemotherapy drugs to cancer cells, they have toxic effects on both cancer cells and normal cells, and besides killing cancer cells, they also have significant harmful effects on normal tissue cells and organ functions. Common toxic side effects of lung cancer chemotherapy are as follows: 1. Bone marrow suppression: Most chemotherapy drugs can cause bone marrow suppression, which is manifested as the decrease of white blood cells and platelets, or even the decrease of red fine chest and hemoglobin. 2, gastrointestinal reactions: appetite, reduced diet, aversion, vomiting, bloating, abdominal pain, diarrhea or constipation, etc. Many chemotherapy drugs affect the mucosa of the gastrointestinal tract to trigger the above performance. 3, cardiotoxicity: some chemotherapy drugs can cause cardiotoxicity, endangering cardiomyocytes, patients present panic, palpitations, chest tightness, precordial discomfort, shortness of breath and other performance, and even present heart failure. 4, liver damage: all chemotherapy drugs can cause liver function harm, patients can present liver function abnormalities and liver discomfort, and even lead to toxic hepatitis. 5, kidney damage: some chemotherapy drugs in high doses can cause kidney function damage and present back pain, kidney discomfort, etc.. There are many drugs that cause kidney damage, such as cisplatin, high-dose MTX and streptomycin, etc. 6, phlebitis: the vast majority of chemotherapy drug delivery method is intravenous drip, can cause a different degree of phlebitis, serious cases can lead to embolic phlebitis, the onset of blood flow obstruction. 7, neurological toxicity: chemotherapy drugs on the peripheral peripheral nerve attack harmful effects, patients can present limb paralysis limb feel dull, and present a different degree of neurotoxic side effects. 8.Allergic reactions: many cytotoxic drugs may cause allergic reactions of different degrees. How to save oneself in the face of painful lung cancer radiotherapy process? The cruelest reality and challenge faced by human beings in treating cancer is: drug resistance and variability. Drug resistance is developed gradually during the treatment process. Patients will achieve efficacy at the beginning of chemotherapy, but as tumor cells become more resistant, the efficacy will become less and less effective. Once cancer cells become resistant, chemotherapy drugs cannot kill cancer cells, but continue to kill normal cells, causing more and more side effects, and eventually there is nothing else to do. Patients during radiotherapy for lung cancer should supplement as much as possible with nutritional supplement health foods that are non-invasive and have complementary benefits with radiotherapy, which can not only reduce the toxic side effects of radiotherapy, but also reduce the drug resistance of cancer cells and enhance their sensitivity to drugs, and at the same time assist and synergize with chemotherapy drug treatment, thus reducing the number and time of chemotherapy and radiotherapy, and can improve the The treatment effect of malignant tumor can be improved without increasing radiation damage, so that the organism can avoid receiving greater harm. Doctor’s suggestion: Patients with lung cancer consume more nutrients, and many complications lead to dietary hindrance, so the main food should be semi-liquid or soft food. Do not consume too much fat, and eat more fresh vegetables and fruits, especially those with anti-cancer effect such as carrot, mushroom, fungus, beans, ergot, yellow cabbage, asparagus, turtle, etc. You can eat more. Supply 10g of fiber and general level of vitamins per day. When the patient after chemotherapy, the phenomenon of white blood cell drop, it will be very likely to cause complications, in this regard, in the diet, we should properly supplement more nutrition, more food such as chicken, duck, fish, meat, milk, soybean products, etc. You can also choose food containing more iron, such as: animal liver, kidney, heart, lean meat, spinach, celery, tomatoes in vegetables, apricots, peaches, plums, raisins in fruits, Dates, pineapple, figs and other foods.